|
BRD8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.038890E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.993010E-04 |
| Normal-vs-Stage2 |
2.519600E-02 |
| Normal-vs-Stage3 |
2.481700E-02 |
| Normal-vs-Stage4 |
2.011800E-02 |
| Stage1-vs-Stage2 |
8.004200E-01 |
| Stage1-vs-Stage3 |
4.681400E-01 |
| Stage1-vs-Stage4 |
6.536400E-01 |
| Stage2-vs-Stage3 |
5.000400E-01 |
| Stage2-vs-Stage4 |
6.015800E-01 |
| Stage3-vs-Stage4 |
8.612200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.620000E-04 |
| Normal-vs-AfricanAmerican |
1.635240E-03 |
| Normal-vs-Asian |
1.444470E-03 |
| Caucasian-vs-AfricanAmerican |
1.802840E-01 |
| Caucasian-vs-Asian |
2.672200E-01 |
| AfricanAmerican-vs-Asian |
5.616200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.415260E-03 |
| Normal-vs-Female |
6.24099999999572E-05 |
| Male-vs-Female |
2.875600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.566800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.79540000000112E-05 |
| Normal-vs-Age(61-80Yrs) |
2.701600E-03 |
| Normal-vs-Age(81-100Yrs) |
4.078400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.594400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.245390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.956500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.436400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.749200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.428000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.856800E-03 |
| Normal-vs-Grade 2 |
1.362750E-04 |
| Normal-vs-Grade 3 |
3.373600E-04 |
| Normal-vs-Grade 4 |
8.594400E-01 |
| Grade 1-vs-Grade 2 |
1.109810E-01 |
| Grade 1-vs-Grade 3 |
1.061190E-01 |
| Grade 1-vs-Grade 4 |
2.427700E-04 |
| Grade 2-vs-Grade 3 |
9.042600E-01 |
| Grade 2-vs-Grade 4 |
8.761500E-04 |
| Grade 3-vs-Grade 4 |
1.720190E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.5037999956391E-08 |
| Normal-vs-ccB subtype |
9.310400E-01 |
| ccA subtype-vs-ccB subtype |
1.24810000112774E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.015400E-04 |
| Normal-vs-N1 |
7.836800E-01 |
| N0-vs-N1 |
2.360000E-01 |
|
|
